Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 63, n° 2
pages 235-243 (août 2010)
Doi : 10.1016/j.jaad.2009.09.017
accepted : 18 September 2009
Original Articles

Body dysmorphic disorder among dermatologic patients: Prevalence and clinical features
 

Luciana Archetti Conrado, MD, PhD a, , Ana Gabriela Hounie, MD, PhD c, Juliana Belo Diniz, MD, PhD c, Victor Fossaluza, MS b, Albina Rodrigues Torres, MD, PhD d, Euripedes Constantino Miguel, MD, PhD c, Evandro Ararigboia Rivitti, MD, PhD a
a Department of Dermatology, University of São Paulo Medical School, São Paulo, Brazil 
c Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil 
b Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil 
d Department of Neurology, Psychology, and Psychiatry of Botucatu Medical School–São Paulo State, Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), São Paulo, Brazil 

Reprint requests: Luciana Archetti Conrado, MD, PhD, Clinica de Dermatologia Luciana Conrado, Rua Caconde, 96/104. CEP: 01425-010. São Paulo/SP Brazil.
Abstract
Background

An impairing preoccupation with a nonexistent or slight defect in appearance is the core symptom of body dysmorphic disorder (BDD), a psychiatric condition common in dermatology settings.

Objective

We sought to determine the prevalence of BDD in dermatologic patients, comparing general and cosmetic settings, and describing some demographic and clinical characteristics.

Methods

In all, 300 patients were consecutively assessed. Screening and diagnoses were performed with validated instruments plus a best estimate diagnosis procedure. The final sample comprised 150 patients in the cosmetic group, 150 patients in the general dermatology group, and 50 control subjects. Standard statistical analyses were performed (χ2, nonparametric tests, logistic regression).

Results

The current prevalence was higher in the cosmetic group (14.0%) compared with general (6.7%) and control (2.0%) groups. No patient had a previous diagnosis. Frequently the reason for seeking dermatologic treatment was not the main BDD preoccupation. Patients with BDD from the cosmetic group were in general unsatisfied with the results of dermatologic treatments.

Limitations

Cross-sectional study conducted in a university hospital is a limitation. It is uncertain if the findings can be generalized. Retrospective data regarding previous treatments are not free from bias.

Conclusions

BDD is relatively common in a dermatologic setting, especially among patients seeking cosmetic treatments. These patients have some different features compared with general dermatology patients. Dermatologists should be aware of the clinical characteristics of BDD to identify and refer these patients to mental health professionals.

The full text of this article is available in PDF format.

Key words : body dysmorphic disorder, body image, body image dissatisfaction, cosmetic procedures, cosmetic treatments, dermatologic symptoms



 Funding sources: None.
 Conflicts of interest: None declared.



© 2009  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline